301 related articles for article (PubMed ID: 1533443)
1. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein.
Yew PR; Berk AJ
Nature; 1992 May; 357(6373):82-5. PubMed ID: 1533443
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus type 5 early region 1B 156R protein promotes cell transformation independently of repression of p53-stimulated transcription.
Sieber T; Dobner T
J Virol; 2007 Jan; 81(1):95-105. PubMed ID: 17050591
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription.
Härtl B; Zeller T; Blanchette P; Kremmer E; Dobner T
Oncogene; 2008 Jun; 27(26):3673-84. PubMed ID: 18212738
[TBL] [Abstract][Full Text] [Related]
4. Control of p53 expression by adenovirus 12 early region 1A and early region 1B 54K proteins.
Grand RJ; Owen D; Rookes SM; Gallimore PH
Virology; 1996 Apr; 218(1):23-34. PubMed ID: 8615026
[TBL] [Abstract][Full Text] [Related]
5. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
6. Consequences of disruption of the interaction between p53 and the larger adenovirus early region 1B protein in adenovirus E1 transformed human cells.
Hutton FG; Turnell AS; Gallimore PH; Grand RJ
Oncogene; 2000 Jan; 19(3):452-62. PubMed ID: 10656694
[TBL] [Abstract][Full Text] [Related]
7. E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells.
Maheswaran S; Englert C; Lee SB; Ezzel RM; Settleman J; Haber DA
Oncogene; 1998 Apr; 16(16):2041-50. PubMed ID: 9572485
[TBL] [Abstract][Full Text] [Related]
8. Functions of the adenovirus E1B tumour antigens.
Stillman B
Cancer Surv; 1986; 5(2):389-404. PubMed ID: 2946407
[TBL] [Abstract][Full Text] [Related]
9. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of the adenovirus 12 E1B 55 kDa oncoprotein and cellular tumor suppressor p53 is sufficient to induce metaphase fragility of the human RNU2 locus.
Liao D; Yu A; Weiner AM
Virology; 1999 Feb; 254(1):11-23. PubMed ID: 9927570
[TBL] [Abstract][Full Text] [Related]
11. Distinct modulation of p53 activity in transcription and cell-cycle regulation by the large (54 kDa) and small (21 kDa) adenovirus E1B proteins.
Steegenga WT; Van Laar T; Shvarts A; Terleth C; Van der Eb AJ; Jochemsen AG
Virology; 1995 Oct; 212(2):543-54. PubMed ID: 7571424
[TBL] [Abstract][Full Text] [Related]
12. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus.
Berk AJ
Oncogene; 2005 Nov; 24(52):7673-85. PubMed ID: 16299528
[TBL] [Abstract][Full Text] [Related]
13. Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with P105-Rb and the transformation of primary mouse cells.
Rumpf H; Esche H; Kirch HC
Virology; 1999 Apr; 257(1):45-53. PubMed ID: 10208919
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of wild-type p53 and c-Myc in human fetal cells transformed with adenovirus early region 1.
Grand RJ; Lecane PS; Roberts S; Grant ML; Lane DP; Young LS; Dawson CW; Gallimore PH
Virology; 1993 Apr; 193(2):579-91. PubMed ID: 8460477
[TBL] [Abstract][Full Text] [Related]
15. The polyproline region of p53 is required to activate apoptosis but not growth arrest.
Sakamuro D; Sabbatini P; White E; Prendergast GC
Oncogene; 1997 Aug; 15(8):887-98. PubMed ID: 9285684
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the E1a gene of type 5 adenovirus result in oncogenic transformation of Fischer rat embryo cells.
Duigou GJ; Babiss LE; Liaw WS; Zimmer SG; Ginsberg HS; Fisher PB
J Cell Biochem; 1987 Feb; 33(2):117-26. PubMed ID: 3571338
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.
Thomas M; Matlashewski G; Pim D; Banks L
Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP.
Sherman L; Itzhaki H; Jackman A; Chen JJ; Koval D; Schlegel R
Virology; 2002 Jan; 292(2):309-20. PubMed ID: 11878933
[TBL] [Abstract][Full Text] [Related]
19. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
Hansen RS; Braithwaite AW
Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
[TBL] [Abstract][Full Text] [Related]
20. Requirement of the C-terminal region of adenovirus E1a for cell transformation in cooperation with E1b.
Subramanian T; Malstrom SE; Chinnadurai G
Oncogene; 1991 Jul; 6(7):1171-3. PubMed ID: 1830644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
